Sutureless Resorbable Anti-Adhesion Films

Information

  • Research Project
  • 7849492
  • ApplicationId
    7849492
  • Core Project Number
    R44GM074373
  • Full Project Number
    5R44GM074373-03
  • Serial Number
    74373
  • FOA Number
    PA-08-050
  • Sub Project Id
  • Project Start Date
    7/1/2005 - 20 years ago
  • Project End Date
    5/31/2012 - 13 years ago
  • Program Officer Name
    MARINO, PAMELA
  • Budget Start Date
    6/1/2010 - 15 years ago
  • Budget End Date
    5/31/2012 - 13 years ago
  • Fiscal Year
    2010
  • Support Year
    3
  • Suffix
  • Award Notice Date
    7/12/2010 - 15 years ago

Sutureless Resorbable Anti-Adhesion Films

DESCRIPTION (provided by applicant): Postoperative adhesions are an expected outcome with nearly every abdominal operation. Complications caused by adhesions include small bowel obstruction, female infertility, chronic debilitating pain, and difficulty in future operations. It has been estimated that in the United States, the total annual cost of removing lower abdominal adhesions exceeds $2 billion in overall inpatient treatment charges, excluding recuperation and lost productivity. Luna Innovations is developing sutureless resorbable adhesive barrier films for the prevention of intra-abdominal post-operative adhesions. Immediate applications include prevention of adhesions after laparotomy and laparoscopy, but the material can be adapted easily to create a family of adhesives or sealants with properties that can be customized for various applications including hemostatic agents, wound dressings, glues and sealants. The novel material consists of surface-modified blends of two abundant and low-cost polymers. The material can be used as a carrier for controlled release of therapeutics. It should also have inherent hemostatic and bacteriostatic properties and the degradation products should stimulate correct deposition, assembly and orientation of collagen fibrils in extracellular matrix components. Physical and mechanical properties, such as strength and degradation rate can be controlled by altering the composition while adhesion to tissue depends, in part, on the surface modification. Cytocompatibility, biodegradability and adhesion to tissue were demonstrated in Phase I. Phase II development will be focused on optimization, comprehensive in vitro and ex vivo testing, and validation in vivo. PUBLIC HEALTH RELEVANCE: Postoperative adhesions are an expected outcome with nearly every abdominal operation. Complications caused by adhesions include small bowel obstruction, female infertility, chronic debilitating pain, and difficulty in future operations. Luna Innovations is developing sutureless resorbable adhesive barrier films for the prevention of intra-abdominal post-surgical adhesions.

IC Name
NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES
  • Activity
    R44
  • Administering IC
    GM
  • Application Type
    5
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
    459978
  • Sub Project Total Cost
  • ARRA Funded
    False
  • CFDA Code
    859
  • Ed Inst. Type
  • Funding ICs
    NIGMS:459978\
  • Funding Mechanism
    SBIR-STTR
  • Study Section
    ZRG1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    LUNA INNOVATIONS, INC.
  • Organization Department
  • Organization DUNS
    627132913
  • Organization City
    ROANOKE
  • Organization State
    VA
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    240164961
  • Organization District
    UNITED STATES